$DARE
Dare Bioscience, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.784
▲+4.88%+$0.036
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateDare Bioscience, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is DARE up today? It is at $0.784 (+4.88%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DARE spikes, and full due diligence on DARE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $DARE 10 times in the last 30 days. Create a free account to track $DARE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on DARE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DARE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCharter / Bylaw Change, from the latest SEC filing. Read it →Across every filing on file, supply equal to 52.6% of the tradeable float is in play - 52.6% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
8,934,345 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Steele Robin Joan Director | Acquired (grant/award) | +27K 0.1% of company | added 100% | 47K | n/a | Jun 30, 26 |
Rastetter William H Director | Acquired (grant/award) | +39K 0.2% of company | added 100% | 40K | n/a | Jun 30, 26 |
Matz Gregory W Director | Acquired (grant/award) | +31K 0.2% of company | added 100% | 31K | n/a | Jun 30, 26 |
Kelley Susan L. Director | Acquired (grant/award) | +24K 0.1% of company | n/a | 24K | n/a | Jun 30, 26 |
Grossman Jessica D. Director | Acquired (grant/award) | +26K 0.1% of company | n/a | 26K | n/a | Jun 30, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on DARE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DARE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
DARE last traded at $0.784, up 4.88% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Dare Bioscience, Inc. Common Stock (DARE) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DARE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DARE 10 times in the last 30 days.
DARE (Dare Bioscience, Inc. Common Stock) trades on XNAS, with a market cap of about $15M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DARE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DARE discussion
Sign in to ask a question or join the discussion.